Identification of novel cps locus polymorphisms in nontypable group B Streptococcus.

Group B Streptococcus (GBS) is an important pathogen responsible for a variety of diseases in newborns and the elderly. A clinical GBS isolate is considered nontypable (NT) when serological methods fail to identify it as one of nine known GBS serotypes. Eight clinical isolates (designated A1-A4, B1-B4) showed PFGE profiles similar to that of a GBS serotype V strain expressing R1, R4 surface proteins. These unique isolates were further characterized by immunologic and genetic methods. Rabbit sera to isolates A1 and A2 reacted weakly with concentrated HCl extracts of A1-A4 isolates, but not with those of B1-B4 isolates. In addition, a type V capsular polysaccharide (CPS) inhibition ELISA revealed that cell wall extracts from isolates A1-A4, but not from B1-B4, expressed low but measurable amounts of type V CPS. Molecular serotyping with PCR analysis showed that all eight isolates contained a type V-specific CPS gene (cpsO) and harboured the gene encoding the surface protein Alp3. Multilocus sequence typing identified isolate A1 as belonging to a new sequence type (ST) designated ST-173, whereas the other seven isolates keyed to ST-1. Sequencing of the 18 genes (17 736 bp) in the cps locus showed that each NT isolate harboured one to three unique polymorphisms, and also identified an IS1381 element in cpsE of the B4 isolate. Collectively, genetic and immunologic analyses revealed that these NT isolates expressing R1, R4 proteins have a genetic profile consistent with that of type V, an emergent, antigenically diverse and increasingly prevalent GBS serotype.

[1]  Jaideep P. Sundaram,et al.  Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome". , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[2]  C. Rubens,et al.  Sialylation of Group B Streptococcal Capsular Polysaccharide Is Mediated by cpsK and Is Required for Optimal Capsule Polymerization and Expression , 2005, Journal of bacteriology.

[3]  H. Tettelin,et al.  Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen , 2005, Science.

[4]  Gustavo Glusman,et al.  Structural and Genetic Diversity of Group B Streptococcus Capsular Polysaccharides , 2005, Infection and Immunity.

[5]  G. Lindahl,et al.  Surface Proteins of Streptococcus agalactiae and Related Proteins in Other Bacterial Pathogens , 2005, Clinical Microbiology Reviews.

[6]  T. Peto,et al.  Hyperinvasive Neonatal Group B Streptococcus Has Arisen from a Bovine Ancestor , 2004, Journal of Clinical Microbiology.

[7]  Jennifer M. Dechaine,et al.  Gene encoding the group B streptococcal protein R4, its presence in clinical reference laboratory isolates & R4 protein pepsin sensitivity. , 2004, The Indian journal of medical research.

[8]  Presence of insertion sequences (IS elements) in group B streptococci of bovine origin. , 2004, The Indian journal of medical research.

[9]  D. Kasper,et al.  Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines. , 2004, The Journal of infectious diseases.

[10]  H. Davies,et al.  Multilocus sequence typing of serotype III group B streptococcus and correlation with pathogenic potential. , 2004, The Journal of infectious diseases.

[11]  A. Dmitriev,et al.  ISSa4-Based Differentiation of Streptococcus agalactiae Strains and Identification of Multiple Target Sites for ISSa4 Insertions , 2004, Journal of bacteriology.

[12]  Mihai Pop,et al.  Using the TIGR assembler in shotgun sequencing projects. , 2004, Methods in molecular biology.

[13]  M. Maiden,et al.  Multi-locus sequence typing: a tool for global epidemiology. , 2003, Trends in microbiology.

[14]  D. Kasper,et al.  Glycoconjugate vaccines to prevent group B streptococcal infections , 2003, Expert opinion on biological therapy.

[15]  Philippe Glaser,et al.  Multilocus Sequence Typing System for Group B Streptococcus , 2003, Journal of Clinical Microbiology.

[16]  Ian T. Paulsen,et al.  Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[17]  H. Slotved,et al.  False-Negative Results in Typing of Group B Streptococci by the Standard Lancefield Antigen Extraction Method , 2002, Journal of Clinical Microbiology.

[18]  F. Kong,et al.  Molecular Profiles of Group B Streptococcal Surface Protein Antigen Genes: Relationship to Molecular Serotypes , 2002, Journal of Clinical Microbiology.

[19]  B. Foxman,et al.  Group B Streptococcus colonization in male and nonpregnant female university students: a cross-sectional prevalence study. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  F. Kong,et al.  Serotype Identification of Group B Streptococci by PCR and Sequencing , 2002, Journal of Clinical Microbiology.

[21]  S. Hillier,et al.  Improved methods for typing nontypeable isolates of group B streptococci. , 2002, International journal of medical microbiology : IJMM.

[22]  E. Bingen,et al.  Clonal Relationship between U.S. and French Serotype V Group B Streptococcus Isolates , 2001, Journal of Clinical Microbiology.

[23]  M. Farley.  Group B streptococcal disease in nonpregnant adults. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  P. Ferrieri,et al.  Rapid Pulsed-Field Gel Electrophoresis Method for Group B Streptococcus Isolates , 2001, Journal of Clinical Microbiology.

[25]  D. Kasper,et al.  Functional Analysis in Type Ia Group B Streptococcusof a Cluster of Genes Involved in Extracellular Polysaccharide Production by Diverse Species of Streptococci* , 2001, The Journal of Biological Chemistry.

[26]  S. Håkansson,et al.  Genotyping of the Capsule Gene Cluster (cps) in Nontypeable Group B Streptococci Reveals Two Majorcps Allelic Variants of Serotypes III and VII , 2000, Journal of Clinical Microbiology.

[27]  C. Rubens,et al.  Analysis of restriction fragment length polymorphisms of the insertion sequence IS1381 in group B Streptococci. , 2000, The Journal of infectious diseases.

[28]  J. Elliott,et al.  Sudden Increase in Isolation of Group B Streptococci, Serotype V, Is Not Due to Emergence of a New Pulsed-Field Gel Electrophoresis Type , 1998, Journal of Clinical Microbiology.

[29]  M. Achtman,et al.  Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  S. Mattingly,et al.  Decreased capacity for type-specific-antigen synthesis accounts for high prevalence of nontypeable strains of group B streptococci in Mexico , 1997, Journal of clinical microbiology.

[31]  J. García,et al.  Identification and characterization of IS1381, a new insertion sequence in Streptococcus pneumoniae , 1997, Journal of bacteriology.

[32]  C. Rubens,et al.  DNA restriction profiles of nontypable group B streptococcal clinical isolates. , 1997, Advances in experimental medicine and biology.

[33]  P. Ferrieri,et al.  Surface protein expression in group B streptococcal invasive isolates. , 1997, Advances in experimental medicine and biology.

[34]  A. Schuchat,et al.  Invasive group B streptococcal disease: the emergence of serotype V. , 1996, The Journal of infectious diseases.

[35]  D H Persing,et al.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing , 1995, Journal of clinical microbiology.

[36]  Owen White,et al.  TIGR Assembler: A New Tool for Assembling Large Shotgun Sequencing Projects , 1995 .

[37]  P. Ferrieri,et al.  Molecular analysis of multiple isolates of the major serotypes of group B streptococci , 1993, Journal of clinical microbiology.

[38]  P. Ferrieri,et al.  Molecular species of R-protein antigens produced by clinical isolates of group B streptococci , 1989, Journal of clinical microbiology.